2014, Number 5
<< Back Next >>
Rev Invest Clin 2014; 66 (5)
Clinical and biochemical findings in Mexican patients with distal renal tubular acidosis
Sandoval TC, Gutiérrez MF, Fernández MRF, Vásquez ME, Moreno CG, Arenas R
Language: English
References: 29
Page: 386-392
PDF size: 174.95 Kb.
ABSTRACT
Introduction. Renal tubular acidosis (RTA) is a rare disease
characterized by a normal serum anion gap, sustained metabolic
acidosis, low concentration of plasma bicarbonate, variable
hyperchloremia and hypokalemia and conserved glomerular
filtration rate. RTA is developed during the first year of life
and produces failure to thrive and anorexia. Primary distal
RTA (type 1) is a renal syndrome with a reduced ability to excrete
the acid load through the collecting ducts and impairment
to concentrate the urine causing polyuria and
dehydration.
Objective. Evaluate the current health status
and describe the clinical findings and progress of Mexican patients
with distal RTA. Demonstrate the distal urinary acidification
defect by measuring the urinary pCO
2 tension in
alkaline urines.
Material and methods. We looked for infants
in tertiary care hospitals with a clinical history of normal
serum anion gap, metabolic acidosis, hypokalemia,
hyperchloremia, nephrocalcinosis, sensorineural hearing loss
and inability for urine acidification under systemic metabolic
acidosis. Biochemical analysis were performed periodically.
Alkali medication was not suspended in one patient to assess
urinary acidification with oral administration of sodium bicarbonate
(2 mEq/Kg) and acetazolamide (500 mg/1.73 m
2
body surface). Urinary pCO
2 levels were determined at 60 and
90 min.
Results. Three children, one adolescent and one
adult with distal RTA were found. They had an infant history
of dehydration, failure to thrive, anorexia, vomiting, muscle
paralysis, hypercalciuria, urinary infections, polyuria, polydipsia
and polyhidramnios during pregnancy. Severe nephrocalcinosis
was detected in all patients whereas sensorineural
hearing loss was developed in four cases. Under the alkali
medication all cases but one were normocalciuric. A patient
developed kidney failure. The urinary acidification test confirmed
the innability to eliminate the acid load.
Conclusion.
Early diagnosis in infancy and continuos alkali medication
were of great benefit for most of the patients. Urinary pCO
2
bilevels
in alkaline urine provided an index for collecting duct
hydrogen-ion secretion. To our knowledge this is the first report
of mexican patients with distal RTA.
REFERENCES
Hamm LL, Simon EE. Roles and mechanisms of urinary buffer excretion. Am J Physiol 1987; 253: F595-F605.
Wagner CA, Devuyst O, Bourgeois S, Mohebbi N. Regulated acid-base transport in the collecting duct. Pflugers Arch 2009; 458: 137-56.
Weiner ID, Verlander JW. Role of NH3 and NH4 transporters in renal acid-base transport. Am J Physiol Renal Physiol 2011; 300: F11-F23.
Carrisoza-Gaytán R, Rangel C, Salvador C, Saldaña-Meyer R, Escalona C, Satlin LM, Liu W, et al. The hyperpolarization-activated cyclic nucleotide-gated HCN2 channel transports ammonium in the distal nephron. Kidney Int 2011; 80: 832-40.
Escobar Pérez LI, Mejía N, Gil H, Santos F. Distal renal tubular acidosis: a hereditary disease with an inadequate urinary H? excretion. Nefrología 2013; 33: 289-96.
Muñoz-Arizpe R, Laura Escobar, Mara Medeiros. Acidosis tubular renal en niños: conceptos actuales de diagnóstico y tratamiento. Renal tubular acidosis in children: state of the art, diagnosis and treatment. Bol Med Hosp Infant Mex 2013; 70: 178-94.
Gil-Peña H, Mejía N, Santos F. Renal tubular acidosis. J Pediatr 2014; 164: 691-8.
Christensen KS. Hypokalemic periodic paralysis secondary to renal tubular acidosis. Eur Neurol 1985; 24: 303-05.
Owen EE, Verner JV. Renal tubular disease with muscle paralysis and hypokalemia. Am J Med 1960; 28: 8-21.
Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, Ozen, et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet 2000; 26: 71-5.
Stover EH, Borthwick KJ, Bavalia C, Eady N, Fritz DM, Rungroj N, et al. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet 2002; 39: 796-803.
Vargas-Poussou R, Houillier P, Le Pottier N, Strompf L, Loirat C, Baudouin V, et al. Genetic investigation of autosomal recessive distal renal tubular acidosis: evidence for early sensorineural hearing loss associated with mutations in the ATP6V0A4 gene. J Am Soc Nephrol 2006; 17: 1437-43.
Elhayek D, Perez de Nanclares G, Chouchane S, Hamami S, Mlika A, Troudi M, Leban N, et al. Molecular diagnosis of distal renal tubular acidosis in Tunisian patients: proposed algorithm for northern Africa populations for the ATP6V1B1, ATP6V0A4 and SCL4A1 genes. BMC Med Genet 2013; 14: 119.
Mejía N, Santos F, Claverie-Martin F, García-Nieto V, Ariceta G, Castaño L, Renal Tube Group. Renal Tube: a network tool for clinical and genetic diagnosis of primary tubulopathies. Eur J Pediatr 2013; 172: 775-80.
Muñoz-Arizpe R, Escobar L, Medeiros M. Over-diagnosis of renal tubular acidosis in México. Rev Invest Clin 2012; 64: 399-401.
Alon U, Hellerstein S, Warady B. Oral acetazolamide in the assessment of (urine-blood) pCO2. Pediatric Nephrol 1991; 5: 307-11.
García Nieto V, Monge M, Hernández Hernández L, Callejón A, Yanes MIL, García Rodríguez VE. Estudio de la capacidad de acidificación renal en niños diagnosticados de hipercalciuria idiopática. Nefrología 2003; XXIII: 219-24.
García Nieto V, Santos F, Rodríguez Iturbe B. Pruebas funcionales renales. En: Nefrología Pediátrica. 2a Ed. García Nieto V, Santos Rodríguez F, Rodríguez-Iturbe B (eds.). Madrid: Aula Médica; 2006, p. 51-6.
Halperin ML, Goldstein MB, Haig A, Johnson MD, Stinebaugh BJ. Studies on the pathogenesis of type I (distal) renal tubular acidosis as revealed by the urinary pCO2 tensions. J Clin Invest 1974; 53: 669-77.
Hirschman GH, Rao DD, Oyemade O, Chan JC. Renal tubular acidosis: practical guides to diagnosis and treatment. Clin Pediatr 1976; 15: 645-50.
Roth KS, Chan JCM. Renal Tubular Acidosis: A new look at an old problem. Clin Pediatr 2001; 40: 533-43.
Gil H, Santos F, García E, Alvarez MV, Ordóñez FA, Málaga S, Coto E. Distal RTA with nerve deafness: clinical spectrum and mutational analysis in five children. Pediatr Nephrol 2007; 22: 825-8.
Tsai HY, Lin SH, Lin CC, Huang FY, Lee MD, Tsai JD. Why is hypercalciuria absent at diagnosis in some children with ATP6V1B1 mutation? Pediatric Nephrol 2011; 26: 1903-07.
Srivastava T, Alon US. Pathophysiology of hypercalciuria in children. Pediatric Nephrol 2007; 22: 1659-73.
Martini LA, Cuppari L, Cunha MA, Schor N, Heilberg IP. Potassium and sodium intake and excretion in calcium stone forming patients. J Ren Nutr 1998; 8: 127-31.
Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urol 2009; 181: 1140-4.
Ayme S, Schmidtke J. Networking for rare diseases. Bundesgesundheitsbl a neccessity for Europe Gesundheitsforsch Gesundheitsschutz 2007; 50: 1477-83.
El Moncer W, Esteban E, Bahri R, Gaya-Vidal M, Carreras-Torres R, Athanasiadis G, Moral P, et al. Mixed origin of the current Tunisian population from the analysis of Alu and Alu/ STR compound systems. J Hum Genet 2010; 55: 827-33.
Rodríguez Soriano J. Renal hereditary tubulopathies: from the clinic to the molecular biology. Nefrología 2003; 23: 71-83.